title: Acute Myeloid Leukemia After Radium-223 Therapy: Case Report.
authors.affiliation: Department of General Internal Medicine, Lahey Clinic, Burlington, MA; Tufts Medical School, Tufts University, Medford, MA. Electronic address: Andreas.varkaris@lahey.org.
authors.forename: Andreas
authors.initials: A
authors.lastname: Varkaris
authors.affiliation: Department of Oncology, Lahey Clinic, Burlington, MA; Tufts Medical School, Tufts University, Medford, MA.
authors.forename: Krishna
authors.initials: K
authors.lastname: Gunturu
authors.affiliation: Department of Hematology, Lahey Clinic, Burlington, MA; Tufts Medical School, Tufts University, Medford, MA.
authors.forename: Tarun
authors.initials: T
authors.lastname: Kewalramani
authors.affiliation: Department of Oncology, Lahey Clinic, Burlington, MA; Tufts Medical School, Tufts University, Medford, MA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Tretter
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000209:etiology*; D008297:Male; D016609:Neoplasms, Second Primary / Q000209:etiology*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000532:radiotherapy; D011883:Radium / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: C000615150:Radium-223; D011883:Radium
keywords: AML; Microenvironment; Prostate Cancer; Radium-223; Secondary leukemia